Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease.

Analysis of the publicly available GSE3365 PBMC transcriptomic dataset revealed significantly elevated PD-1 expression in patients with CD compared with healthy controls, whereas those with UC showed the same increasing trend but did not reach statistical significance (Fig. 4b ).

also in 111,027 other papers